Literature DB >> 23592905

microRNAs and ceRNAs: RNA networks in pathogenesis of cancer.

Xiangqian Su1, Jiadi Xing, Zaozao Wang, Lei Chen, Ming Cui, Beihai Jiang.   

Abstract

microRNAs (miRNAs) are a class of endogenous, single-stranded non-coding RNAs of 20-23 nucleotides in length, functioning as negative regulators of gene expression at the post-transcriptional level. The dysregulation of miRNAs has been demonstrated to play critical roles in tumorigenesis, either through inhibiting tumor suppressor genes or activating oncogenes inappropriately. Besides their promising clinical applications in cancer diagnosis and treatment, recent studies have uncovered that miRNAs could act as a regulatory language, through which messenger RNAs, transcribed pseudogenes, and long noncoding RNAs crosstalk with each other and form a novel regulatory network. RNA transcripts involved in this network have been termed as competing endogenous RNAs (ceRNAs), since they influence each other's level by competing for the same pool of miRNAs through miRNA response elements (MREs) on their target transcripts. The discovery of miRNA-ceRNA network not only provides the possibility of an additional level of post-transcriptional regulation, but also dictates a reassessment of the existing regulatory pathways involved in cancer initiation and progression.

Entities:  

Keywords:  cancer; ceRNA; miRNA

Year:  2013        PMID: 23592905      PMCID: PMC3626990          DOI: 10.3978/j.issn.1000-9604.2013.03.08

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  30 in total

1.  New competition in RNA regulation.

Authors:  Anastasia Khvorova; Alexey Wolfson
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

2.  An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma.

Authors:  Pavel Sumazin; Xuerui Yang; Hua-Sheng Chiu; Wei-Jen Chung; Archana Iyer; David Llobet-Navas; Presha Rajbhandari; Mukesh Bansal; Paolo Guarnieri; Jose Silva; Andrea Califano
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

3.  Stable knockdown of microRNA in vivo by lentiviral vectors.

Authors:  Bernhard Gentner; Giulia Schira; Alice Giustacchini; Mario Amendola; Brian D Brown; Maurilio Ponzoni; Luigi Naldini
Journal:  Nat Methods       Date:  2008-11-30       Impact factor: 28.547

4.  Redefining microRNA targets.

Authors:  Hervé Seitz
Journal:  Curr Biol       Date:  2009-04-16       Impact factor: 10.834

5.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

6.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals.

Authors:  Mitchell Guttman; Ido Amit; Manuel Garber; Courtney French; Michael F Lin; David Feldser; Maite Huarte; Or Zuk; Bryce W Carey; John P Cassady; Moran N Cabili; Rudolf Jaenisch; Tarjei S Mikkelsen; Tyler Jacks; Nir Hacohen; Bradley E Bernstein; Manolis Kellis; Aviv Regev; John L Rinn; Eric S Lander
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

7.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

8.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.

Authors:  Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

9.  CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer.

Authors:  Jiayi Wang; Xiangfan Liu; Huacheng Wu; Peihua Ni; Zhidong Gu; Yongxia Qiao; Ning Chen; Fenyong Sun; Qishi Fan
Journal:  Nucleic Acids Res       Date:  2010-04-27       Impact factor: 16.971

10.  Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms.

Authors:  Carlos M Loya; Cecilia S Lu; David Van Vactor; Tudor A Fulga
Journal:  Nat Methods       Date:  2009-11-15       Impact factor: 28.547

View more
  38 in total

1.  A PTEN translational isoform has PTEN-like activity.

Authors:  Xie Zhang; Bowei Yin; Fangfang Zhu; Guochang Huang; Hong Li
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

Review 2.  Competing endogenous RNA networks and gastric cancer.

Authors:  Lei-Lei Guo; Chun-Hua Song; Peng Wang; Li-Ping Dai; Jian-Ying Zhang; Kai-Juan Wang
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

3.  Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases.

Authors:  Qinghai Zeng; Cuihong Jin; Wenhang Chen; Fang Xia; Qi Wang; Fan Fan; Juan Du; Yihang Guo; Changwei Lin; Kaiyan Yang; Jingjing Li; Xiaowei Peng; Xiaorong Li; Ke Cao
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

Review 4.  Levels of MicroRNA Heterogeneity in Cancer Biology.

Authors:  Nina Petrovic; Sercan Ergün; Esma R Isenovic
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

5.  Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.

Authors:  G X Feng; J Li; Z Yang; S Q Zhang; Y X Liu; W Y Zhang; L H Ye; X D Zhang
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

6.  High expression of long non-coding RNA NNT-AS1 facilitates progression of cholangiocarcinoma through promoting epithelial-mesenchymal transition.

Authors:  Yulei Gu; Chao Li; Lili Xiao; Juan Li; Hui Pei; Dong Xu; Yumin Jiang; Xiaofan Zhang; Luanluan Zhang; Kongfei Li; Zhiqiang Zhu; Xiaolong Chen
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

7.  Upregulation of the long non-coding RNA FOXD2-AS1 is correlated with tumor progression and metastasis in papillary thyroid cancer.

Authors:  Hongqiang Li; Qicai Han; Yali Chen; Xiaolong Chen; Runsheng Ma; Qungang Chang; Detao Yin
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

8.  Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme.

Authors:  Jia-Bin Wang; Feng-Hua Liu; Jian-Hang Chen; Hai-Tao Ge; Lu-Yan Mu; Hong-Bo Bao; Zhi-Guo Lin
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-06       Impact factor: 4.553

Review 9.  Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.

Authors:  Sercan Ergun; Serdar Oztuzcu
Journal:  Tumour Biol       Date:  2015-03-27

10.  Molecular Expression of Some Oncogenes and Predisposing Behaviors Contributing to the Aggressiveness of Prostate Cancer.

Authors:  Mohammad Ghasem Kashanizadeh; Fariba Rezaei Fakhrnezhad; Saeede Yavari; Homa Alizadeh; Payam Hashemim; Amir Monfaredan
Journal:  Rep Biochem Mol Biol       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.